Mutated in Colorectal Cancers (MCC) (AA 88-103), (pSer102) peptide
Description
Heteroclitic peptide [Ser 102] moth cytochrome c mutant, is equivalent to the native peptide in its capacity to promote the early phases of T-cell activation. It could be used as a partial agonist for several cell lines, as oppose to the wild type MCC.